The Role of Sandostatin in Treating Carcinoid Cancer

The role of Sandostain in treating Carcinoid Cancer and related Neuroendocrine Cancers will be the focus of the March 12th meeting of PCCAN. Wendy King of Novartis, the maker of Sandostatin, is our guest speaker. The meeting will be held from 2 pm to 4 pm, in dining room A at Hershey Medical Center.

Please RSVP for the meeting with PCCAN at CarcinoidSupport@juno.com or at 717-576-5095.